Back to Search
JEREMY KORTMANSKY, MD
MD
Hematology & Oncology Physician
NPI: 1801835756IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
043345(CT)
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1996
Research & Publications (7)
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.
PMID 19451750·Pancreatology·2009
3-trial
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
PMID 17878176·Ann Oncol·2008
3-trial
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
PMID 17031397·Br J Cancer·2006
3-trial
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
PMID 15897584·Clin Cancer Res·2005
3-trial
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
PMID 15699481·J Clin Oncol·2005
3-trial
Bryostatin-1: a novel PKC inhibitor in clinical development.
PMID 14735696·Cancer Invest·2003
6-review
The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
PMID 14676132·Clin Cancer Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2080 WHITNEY AVE, SUITE 240
HAMDEN, CT 06518 - Phone
- (203) 407-8002
Quick Facts
- NPI
- 1801835756
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 7
Are you this provider?
Claim Your Profile